Published in J Exp Med on December 01, 1994
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 13.05
Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol (1998) 2.49
Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med (1997) 2.14
Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun (2004) 2.04
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest (1996) 1.99
Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest (2009) 1.87
Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun (2001) 1.76
Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg (2004) 1.65
Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun (2003) 1.55
Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin Immunopathol (2013) 1.54
Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev (2003) 1.45
Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun (2002) 1.39
PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway. J Immunol (2012) 1.35
Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci U S A (1996) 1.34
Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol (2001) 1.30
Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem (2008) 1.29
Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc Natl Acad Sci U S A (1996) 1.28
Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin Immunol (2009) 1.27
Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology (1997) 1.24
Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun (2004) 1.24
Extrinsic and intrinsic control of macrophage inflammatory responses. J Leukoc Biol (2013) 1.23
COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostaglandins Other Lipid Mediat (2011) 1.20
Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest (1998) 1.20
Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg (2005) 1.11
Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology (2004) 1.10
Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin 10. Infect Immun (2001) 1.08
Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun (2013) 1.05
Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway. J Leukoc Biol (2008) 1.04
Characterization of prostaglandin E2 production by Candida albicans. Infect Immun (2007) 1.04
Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis. Gut (2006) 1.03
Fluorescent imaging of antigen released by a skin-invading helminth reveals differential uptake and activation profiles by antigen presenting cells. PLoS Negl Trop Dis (2009) 1.02
Effects of lornoxicam on the physiology of severe sepsis. Crit Care (2004) 1.01
Salmonella enterica serovar Typhimurium infection induces cyclooxygenase 2 expression in macrophages: involvement of Salmonella pathogenicity island 2. Infect Immun (2004) 1.01
The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages. J Immunol (2009) 1.00
Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology (1997) 0.99
Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs. Mediators Inflamm (2012) 0.97
Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide-activated macrophages toward M2 phenotype. J Biol Chem (2013) 0.97
PGE(2) suppression of innate immunity during mucosal bacterial infection. Front Cell Infect Microbiol (2013) 0.96
Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol (2007) 0.95
Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol (2000) 0.95
Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins. Brain Behav Immun (2008) 0.92
Pattern recognition receptors in innate immunity, host defense, and immunopathology. Adv Physiol Educ (2013) 0.92
Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med (1997) 0.92
Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat Med (2015) 0.91
Salmonella pathogenicity island 2-dependent expression of suppressor of cytokine signaling 3 in macrophages. Infect Immun (2005) 0.91
Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells. Immunology (2006) 0.91
Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver. Clin Exp Metastasis (2011) 0.88
Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells. J Clin Invest (1997) 0.88
Differential susceptibility of P-glycoprotein deficient mice to colitis induction by environmental insults. Inflamm Bowel Dis (2009) 0.88
Monocyte deactivation correlates with injury severity score, but not with heme oxygenase-1 levels in trauma patients. J Surg Res (2011) 0.88
Induction of M2 regulatory macrophages through the β2-adrenergic receptor with protection during endotoxemia and acute lung injury. J Innate Immun (2014) 0.87
Francisella tularensis elicits IL-10 via a PGE₂-inducible factor, to drive macrophage MARCH1 expression and class II down-regulation. PLoS One (2012) 0.86
Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis. BMC Bioinformatics (2013) 0.86
Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. Proc Natl Acad Sci U S A (1995) 0.85
Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase. Immunology (2007) 0.85
The effect of phospholipase A2 from Crotalus durissus collilineatus on Leishmania (Leishmania) amazonensis infection. Parasitol Res (2008) 0.84
Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli. Br J Pharmacol (1999) 0.82
Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10. Br J Pharmacol (2001) 0.82
Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts. Inflammation (2001) 0.80
Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC). Clin Exp Immunol (1999) 0.80
Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9. Infect Immun (2005) 0.80
Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response. Cancer Immunol Immunother (2009) 0.80
Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. Immunology (2001) 0.79
Prostaglandin E2 downregulates interferon-gamma-induced intercellular adhesion molecule-1 expression via EP2 receptors in human gingival fibroblasts. Inflammation (1999) 0.79
Role of cyclooxygenase enzymes in a murine model of experimental cholera. Infect Immun (2003) 0.78
Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells. Br J Pharmacol (2016) 0.77
Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure. Tex Heart Inst J (2010) 0.77
Granulocyte-macrophage colony-stimulating factor (GM-CSF) has opposing effects on the capacity of monocytes versus monocyte-derived dendritic cells to stimulate the antigen-specific proliferation of a human T cell clone. Clin Exp Immunol (2000) 0.77
Expression patterns of immune genes in long-term cultured dental stem cells. Clin Oral Investig (2015) 0.76
Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation. Am J Physiol Lung Cell Mol Physiol (2014) 0.76
The protective effect and mechanism of sevoflurane on LPS-induced acute lung injury in mice. Am J Transl Res (2017) 0.75
Simultaneous Pathway Activity Inference and Gene Expression Analysis Using RNA Sequencing. Cell Syst (2016) 0.75
Role of transforming growth factor-beta(1) in down-regulating TNF production by alveolar macrophages during asbestos-induced pulmonary fibrosis. Mediators Inflamm (1996) 0.75
Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-α Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism. PLoS One (2015) 0.75
The acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient mice. Mediators Inflamm (2014) 0.75
Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol (1988) 14.21
IL-10 inhibits cytokine production by activated macrophages. J Immunol (1991) 13.13
The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol (1989) 9.63
The pathophysiology of tumor necrosis factors. Annu Rev Immunol (1992) 8.38
Macrophage deactivation by interleukin 10. J Exp Med (1991) 6.94
Deactivation of macrophages by transforming growth factor-beta. Nature (1988) 5.56
Interleukin 10 protects mice from lethal endotoxemia. J Exp Med (1993) 4.46
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem (1988) 4.44
Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci U S A (1989) 4.01
Prostaglandins modulate macrophage Ia expression. Nature (1982) 3.83
Biological properties of interleukin 10. Immunol Today (1992) 3.62
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today (1994) 3.25
Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. Biochem Biophys Res Commun (1986) 2.96
Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest (1992) 2.63
Biological properties of interleukin 10. J Clin Immunol (1992) 2.50
Effect of prostaglandin E 1 on adjuvant arthritis. Nature (1971) 2.02
Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun (1986) 1.95
Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J Immunol (1989) 1.65
Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E. J Immunol (1981) 1.55
Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum (1977) 1.38
Tumor necrosis factor-induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP. J Immunol (1988) 1.15
The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine (1993) 1.08
Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J Exp Med (1993) 1.07
Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment. Mol Cell Endocrinol (1981) 1.00
Regulation of murine mononuclear phagocyte inflammatory products by macrophage colony-stimulating factor. Lack of IL-1 and prostaglandin E2 production and generation of a specific IL-1 inhibitor. J Immunol (1991) 0.99
Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis. J Clin Invest (1987) 0.93
Suppression of human lymphocyte migration by PGE2. Inflammation (1981) 0.88
Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol (1994) 3.32
Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis. J Exp Med (1993) 2.88
Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest (1992) 2.63
CD8+ T cells can be primed in vitro to produce IL-4. J Immunol (1992) 1.91
Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc Natl Acad Sci U S A (1994) 1.77
Species dependent differences in the actions of sympathetic nerves and noradrenaline in the internal anal sphincter. Neurogastroenterol Motil (2007) 1.65
Sterile protection of monkeys against malaria after administration of interleukin-12. Nat Med (1997) 1.48
CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J Immunol (2000) 1.41
Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. J Immunol (1998) 1.28
Changes in excitability of the cortical projections to the human tibialis anterior after paired associative stimulation. J Neurophysiol (2007) 1.15
Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas. Antimicrob Agents Chemother (1990) 1.14
Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse. J Exp Med (1996) 1.13
The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine (1993) 1.08
Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. J Clin Invest (1993) 1.07
Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol (1995) 1.06
Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol (1999) 1.05
Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. J Immunol (1993) 1.04
Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10. J Immunol (1995) 1.01
Acquisition of cell surface IgD after in vitro culture of neoplastic B cells from the murine tumor BCL1. J Exp Med (1980) 1.01
Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. J Immunol (1992) 0.99
Regulation of murine mononuclear phagocyte inflammatory products by macrophage colony-stimulating factor. Lack of IL-1 and prostaglandin E2 production and generation of a specific IL-1 inhibitor. J Immunol (1991) 0.99
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood (2000) 0.98
The house dust mite allergen, Dermatophagoides pteronyssinus, promotes type 2 responses by modulating the balance between IL-4 and IFN-gamma. J Immunol (1998) 0.97
Mechanisms of action of genes controlling the immune response. Transplant Proc (1975) 0.95
IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation. J Immunol (1994) 0.93
Induction of B cell apoptosis by co-cross-linking CD23 and sIg involves aberrant regulation of c-myc and is inhibited by bcl-2. Int Immunol (1997) 0.89
Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease. Parasite Immunol (1999) 0.88
Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy. Cytokines Mol Ther (1995) 0.87
The development of IgE+ memory B cells following primary IgE immune responses. Eur J Immunol (1996) 0.87
An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo. Cancer Gene Ther (1995) 0.86
Alteration of the B cell surface phenotype, immune response to phosphocholine and the B cell repertoire in M167 mu plus kappa transgenic mice. J Immunol (1989) 0.86
Exposure to crosslinked IgD induces receptors for IgD on T cells in vivo and in vitro. Proc Natl Acad Sci U S A (1988) 0.85
Complicating risk factors for pyelonephritis after extracorporeal shock wave lithotripsy. Int J Urol (2000) 0.84
The immunomodulator AS-101 inhibits IL-10 release and augments TNF alpha and IL-1 alpha release by mouse and human mononuclear phagocytes. Cell Immunol (1997) 0.83
Acute effects of ethanol on hepatic protein synthesis and secretion in the rat. Gastroenterology (1980) 0.83
Effect of increased systemic venous pressure on thoracic duct and peripheral lymph flow in dogs. Lymphology (1985) 0.81
Vesnarinone is a selective inhibitor of macrophage TNF(alpha) release. Int J Immunopharmacol (1997) 0.81
Release of IgD-binding factor by T cells under the influence of interleukin 2, interleukin 4, or cross-linked IgD. Proc Natl Acad Sci U S A (1988) 0.81
Interplay between inhibition of adenosine uptake and phosphodiesterase type 3 on cardiac function by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol (2001) 0.81
Exaggerated acetaldehyde response after ethanol administration during pregnancy and lactation in rats. Alcohol Clin Exp Res (1985) 0.81
The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia. Cancer Lett (1996) 0.80
Crystal structures and transistor properties of phenyl-substituted tetrathiafulvalene derivatives. Nanotechnology (2007) 0.80
Mechanisms of paraneoplastic syndromes of colon-26: involvement of interleukin 6 in hypercalcemia. Cytokine (1993) 0.80
Monte Carlo calculation of dose distributions in oligometastatic patients planned for spine stereotactic ablative radiotherapy. Phys Med Biol (2013) 0.79
Reactivity of lupus erythematosus antibodies with leukemic helper T cells. J Invest Dermatol (1978) 0.79
Fas activation reduces neutrophil adhesion to endothelial cells. J Leukoc Biol (2000) 0.79
Role of interleukin-4 in the development of allergic airway inflammation and airway hyperresponsiveness. Adv Exp Med Biol (1996) 0.78
8-Mercaptoguanosine-mediated enhancement of in vivo IgG1, IgG2 and IgG3 antibody responses to polysaccharide antigens in normal and xid mice. Immunopharmacology (1990) 0.78
Enhanced immunogenicity of protein-dextran conjugates: I. Rapid stimulation of enhanced antibody responses to poorly immunogenic molecules. Vaccine (1994) 0.78
Inhibition of adenosine uptake and augmentation of ischemia-induced increase of interstitial adenosine by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol (2000) 0.78
Fluid deficits and hypotension during colonoscopy. Anaesth Intensive Care (2006) 0.78
Do allergens induce type-2 immune responses? Int Arch Allergy Immunol (1999) 0.78
A modified colchicine-binding assay for the measurement of total and microtubule-derived tubulin in rat liver. Anal Biochem (1983) 0.78
Inhibition of lipopolysaccharide and IL-1 but not of TNF-induced activation of human endothelial cells by suramin. J Immunol (1994) 0.77
Comparison of tyrosine kinase activation by mitogenic and nonmitogenic anti-IgD antibodies. J Immunol (1992) 0.77
Cytokine response to BCG infection in alcohol-fed mice. Alcohol (1999) 0.77
Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities. Int J Immunopharmacol (1994) 0.77
Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response. Gene Ther (2001) 0.77
Neutrophils augment the release of TNFalpha from LPS-stimulated macrophages via hydrogen peroxide. Immunol Lett (2000) 0.77
Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury. Int J Immunopharmacol (1997) 0.76
[Clinical effect of allylestrenol on benign prostatic hypertrophy]. Hinyokika Kiyo (1986) 0.75
Tumor cell IL-6 gene expression is regulated by IL-1 alpha/beta and TNF alpha: proposed feedback mechanisms induced by the interaction of tumor cells and macrophages. J Leukoc Biol (1992) 0.75
Increase of the expression of midecamycin 4"-hydroxyl propionyltransferase gene (mpt) by a promoter-like fragment from the midecamycin producing strain. Chin J Biotechnol (1996) 0.75
Dose rate and repair effects on cell damage in Earth orbit. Adv Space Res (1994) 0.75
Reevaluation of the effects of alcohol consumption on rat liver microtubules: effects of feeding status. Res Commun Chem Pathol Pharmacol (1984) 0.75
[Ultrasonically guided puncture of the prostate and seminal vesicles]. Hinyokika Kiyo (1985) 0.75
Prognosis and histology in Stage I nasopharyngeal carcinoma (NPC). Int J Radiat Oncol Biol Phys (1985) 0.75
[A case of fulminant hepatitis after reexposure to halothane six years later]. Masui (1989) 0.75
Siphoning from a syringe pump: a cause of sudden overdose. Anaesth Intensive Care (1983) 0.75
Identification of terminal N-acetylglucosamine residues of highly branched asparagine-linked oligosaccharides as immunoreactive domains of a chicken heterophile antigenic determinant. Mol Immunol (1987) 0.75
Oliguria, fever, and graft swelling after renal transplantation: were the symptoms really caused by acute rejection? Clin Transpl (1986) 0.75
Epidural abscess after spinal anaesthesia. Anaesth Intensive Care (2000) 0.75
Lactic acid tolerance in phenformin-treated animals. Ann N Y Acad Sci (1968) 0.75
[Case of intralobar pulmonary sequestration--with special reference to demonstration of abnormal arteries by computed tomography]. Nihon Kyobu Shikkan Gakkai Zasshi (1983) 0.75
[Results of the treatment of prostatic cancer]. Nihon Hinyokika Gakkai Zasshi (1989) 0.75
Piloting the CANRISK tool in Vancouver Coastal Health. Chronic Dis Inj Can (2011) 0.75
Which should be inserted first--giving set or airway? Anaesth Intensive Care (2001) 0.75
The status of women, population and development. Newsl Int Union Sci Study Popul (1985) 0.75
Chicken mucin-cross-reactive antigen. Dev Comp Immunol (1988) 0.75
Students' tactics of resistance and teachers' stress. Percept Mot Skills (1997) 0.75
Ir genes and antigen recognition. Ann N Y Acad Sci (1975) 0.75
A series of murine interleukin molecules which stimulate both murine and human lymphocytes. I. Production by Phytolacca americana (pokeweed) lectin 2 (Pa-2)-stimulated thymus and thymus-derived cells. Cell Immunol (1981) 0.75
Vesnarinone inhibits adenosine uptake in endothelial cells, smooth muscle cells and myocytes, and mediates cytoprotection. J Mol Cell Cardiol (1997) 0.75
Effects of ethanol on hepatic protein secretion and microtubules. Possible mediation by acetaldehyde. Curr Alcohol (1981) 0.75
Opto-isolated stimulators used for electrically evoked BSER: some observations on electrical artifact. Ann Otol Rhinol Laryngol Suppl (1981) 0.75